Cargando…
Drug repurposing using computational methods to identify therapeutic options for COVID-19
PURPOSE: Recently, the world has been dealing with a new type of coronavirus called COVID-19 that in terms of symptoms is similar to the SARS coronavirus. Unfortunately, researchers could not find a registered therapy to treat the infection related to the virus yet. Regarding the fact that drug repu...
Autores principales: | Mahdian, Soodeh, Ebrahim-Habibi, Azadeh, Zarrabi, Mahboobeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261216/ https://www.ncbi.nlm.nih.gov/pubmed/32837954 http://dx.doi.org/10.1007/s40200-020-00546-9 |
Ejemplares similares
-
Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations
por: Mahdian, Soodeh, et al.
Publicado: (2021) -
Corrigendum to ‟Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsˮ [Inform. Med. Unlocked 23 (2021) 1-9/100541]
por: Mahdian, Soodeh, et al.
Publicado: (2023) -
In silico evidence for prednisone and progesterone efficacy in recurrent implantation failure treatment
por: Mahdian, Soodeh, et al.
Publicado: (2022) -
A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19
por: Khurana, Pankaj, et al.
Publicado: (2022) -
Computational-based drug repurposing methods in COVID-19
por: Masoudi-Sobhanzadeh, Yosef
Publicado: (2020)